Canada - français - Health Canada

biogen canada inc - peginterfÉron bÊta-1a; peginterfÉron bÊta-1a - trousse - 63mcg; 94mcg - peginterfÉron bÊta-1a 63mcg; peginterfÉron bÊta-1a 94mcg - interferons

Canada - français - Health Canada

emd serono, a division of emd inc., canada - interféron bêta-1a; interféron bêta-1a - trousse - 8.8mcg; 22mcg - interféron bêta-1a 8.8mcg; interféron bêta-1a 22mcg - immunomodulatory agents

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - interferonum bêta-1a adnr - solution injectable dans une seringue préremplie - interferonum beta-1a adnr 30 µg corresp. 6 mio u.i., natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, arginini hydrochloridum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - interferonum bêta-1a adnr - solution injectable en stylo prérempli - interferonum beta-1a adnr 30 µg corresp. 6 mio u.i., natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, arginini hydrochloridum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en stylo prérempli - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en stylo prérempli - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.06 mg. - multiple sklerose - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.1 mg. - multiple sklerose - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.02 mg. - multiple sklerose - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika